TCL Archive Organ Site Review Committee Recommends Continuing Program Despite Some Weak Areas, Suggests Changes February 5, 1982
TCL Archive Adverse data from cancer prevention trial makes Merck withdraw Vioxx from market. Researchers discuss implications for other cancer prevention trials. October 15, 2004